Abstract
Inputs from central (brainstem) and peripheral (carotid body) respiratory chemoreceptors are coordinated to protect blood gases against potentially deleterious fluctuations. However, the mathematics of the steady-state interaction between chemoreceptors has been difficult to ascertain. Further, how this interaction affects time-dependent phenomena (in which chemoresponses depend upon previous experience) is largely unknown. To determine how central PCO2 modulates the response to peripheral chemostimulation in the rat, we utilized an in situ arterially perfused, vagotomized, decerebrate preparation, in which central and peripheral chemoreceptors were perfused separately (i.e. dual perfused preparation (DPP)). We carried out two sets of experiments: in Experiment 1, we alternated steady-state brainstem PCO2 between 25 and 50 Torr in each preparation, and applied specific carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2) under both conditions; in Experiment 2, we applied four 5 min bouts (separated by 5 min) of specific carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2) while holding the brainstem at either 30 Torr or 50 Torr PCO2. We demonstrate that the level of brainstem PCO2 modulates (a) the magnitude of the phrenic responses to a single step of specific carotid body hypoxia and (b) the magnitude of time-dependent phenomena. We report that the interaction between chemoreceptors is negative (i.e. hypo-additive), whereby a lower brainstem PCO2 augments phrenic responses resulting from specific carotid body hypoxia. A negative interaction may underlie the pathophysiology of central sleep apnoea in populations that are chronically hypocapnic.
The chemical-dependent regulation of blood gasses is co-ordinated through central and peripheral respiratory chemoreceptor feedback loops (e.g. Cunningham et al. 1986; Topor et al. 2004). The central respiratory chemoreceptors are located within the brainstem and respond to changes in tissue pH/CO2 (Nattie, 2000). The peripheral (carotid body) respiratory chemoreceptors, located at the bifurcation of the common carotid arteries, respond to changes in both arterial PO2 and PCO2 (Lahiri & DeLaney, 1975). Recently, considerable advances have been made toward locating and characterizing the phenotype of putative central chemoreceptors (Guyenet et al. 2005; Richerson et al. 2005) and determining the signal transduction mechanism involved in peripheral chemosensitivity (Lahiri et al. 2006; Prabhakar, 2006). Rodent preparations have been used extensively in these studies. However, the fundamental question as to how central and peripheral chemoreceptors interact to produce ventilatory responses remains contentious, and testing this interaction experimentally in small mammals, such as rodents, has not been attempted.
In non-rodent preparations, the mathematics of the interaction between central and peripheral respiratory chemoreceptors has been reported to be: (a) additive, where the contribution of the two receptor compartments do not interact in any significant way (van Beek et al. 1983; Daristotle & Bisgard, 1989; Clement et al. 1992, 1995; St. Croix et al. 1996;); (b) positive (i.e. hyper-additive; Adams et al. 1978; Robbins, 1988); and (c) negative (i.e. hypo-additive; Gesell et al. 1940; Giese et al. 1978; Berger et al. 1978; Eldridge et al. 1981; Adams & Severns, 1982; Smith et al. 1984).
The uncertainty regarding the nature of central and peripheral chemoreceptor interaction is further confounded by ventilatory time-dependent phenomena, which influence the dynamics of chemoresponses relative to previous experience. Numerous time-dependent responses to chemostimuli have been described (see Powell et al. 1998 for review), including hypoxic ventilatory decline (HVD) (Robbins, 1995), short-term potentiation or ventilatory after-discharge (STP or VAD, respectively) (Eldridge & Millhorn, 1986; Engwall et al. 1991), post-hypoxic frequency decline (PHxFD) (Hayashi et al. 1993; Coles & Dick, 1996; Dick & Coles, 2000; Day & Wilson, 2005), progressive augmentation (PA) (Millhorn et al. 1980; Fregosi & Mitchell, 1994; Turner & Mitchell, 1997; Day & Wilson, 2005) and long-term facilitation (LTF) (Baker & Mitchell, 2000; Olson et al. 2001). These time-dependent phenomena are likely to be important in the stability of breathing, and their magnitude may depend on chemoreceptor interaction.
To facilitate the study of central and peripheral chemoreceptor interaction we developed a novel in situ dual perfused rat preparation (DPP) based on the working heart–brainstem preparation (WHBP) (Paton, 1996). The WHBP has a well-oxygenated brainstem (>200 Torr PO2), a pH that matches the perfusate, intact vascular responses to PO2 and PCO2, and a eupnoeic-like ramping phrenic discharge (Wilson et al. 2001). In the DPP, central (brainstem) and peripheral (carotid body) compartments are perfused separately, allowing compartment-specific chemochallenges with defined medium containing precisely controlled gas concentrations. We have previously demonstrated (a) the independence of peripheral and central perfusion circuits, and (b) that specific carotid body intermittent hypoxia is sufficient to elicit a number of time-dependent phenomena (Day & Wilson, 2005).
In the present study, we tested whether the level of steady-state brainstem PCO2 modulates components of the phrenic response resulting from specific carotid body hypoxia. Specifically, we investigated phrenic responses to single and intermittent bouts of carotid body hypoxia under differing levels of steady-state brainstem PCO2. Here we provide data to demonstrate that the level of brainstem PCO2 modulates (a) the magnitude of the phrenic responses to a single bout of specific isocapnic carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2), and (b) the magnitude of time-dependent phenomena resulting from intermittent isocapnic hypoxia.
Methods
In situ DPP
We modified the WHBP (Paton, 1996), making it appropriate for studies of respiratory chemoreceptor interaction. We will refer to our preparation as the in situ DPP (Day & Wilson, 2005). Our modifications include: (a) separate perfusion of central and peripheral chemoreceptor compartments, (b) clamping of descending aorta perfusion pressures at ∼90 mmHg via computer feedback control, (c) vagotomy, and (d) normokalaemic perfusate.
Dissection and perfusion system
Experiments were conducted using juvenile male Sprague-Dawley albino rats (Charles River, Quebec, Canada; 120–150 g, ∼4–6 weeks old) and 23 animals were included in the study. Experimental procedures were approved by the University of Calgary Animal Care Committee and were in accordance with national guidelines. Procedures were identical to a previous study (Day & Wilson, 2005). Briefly, rats were heparinized (1500 units i.p.) ∼15–30 min prior to being anaesthetized for dissection. Deep anaesthesia was induced using an overdose of halothane via inhalation. Adequate anaesthesia was assessed by testing for absence of response to noxious tail pinch. In rapid succession, rats were transected subdiaphragmatically and decerebrated at the midcollicular level. The decerebration was performed with a vertical cut using a new scalpel, removing all tissue rostral and dorsal to the colliculi. Transection and decerebration were performed in cold perfusate (∼5–8°C, 500 ml volume) containing (mm): 115 NaCl, 24 NaHCO3, 4 KCl, 2 CaCl2, 1 MgSO4, 1.25 NaH2PO4 and 10 dextrose, and equilibrated with 95% O2–5% CO2. The skin was removed, and the preparation was placed into an experimental chamber and secured with ear bars. The descending aorta was canulated with a double-lumen catheter. One lumen of the catheter was connected to a peristaltic pump (Gilson Minipuls 3) and used to perfuse the descending aorta retrogradely with room-temperature perfusate containing 1.33% Ficoll Type-70 (Sigma-Aldrich F-2878) equilibrated with 40 Torr PCO2 in O2. The other lumen was attached to a pressure transducer to monitor perfusion pressure. Once canulated, the speed of the peristaltic pump was increased so as to increase perfusion pressure to ∼90 mmHg using a custom-built computer-controlled feedback system. A bilateral vagotomy was performed at the mid-cervical level. The common carotid arteries were tied off above the clavicles and canulated proximal to the carotid bodies. A separate peristaltic pump with two channels was used to perfuse the common carotid arteries at ∼15–20 ml min−1 per carotid. Up to this stage in the dissection, central and peripheral perfusion was from the same tonometer (∼300 ml).
Independent perfusion of central (descending aorta) and peripheral (carotid arteries) circuits was then initiated by pulling fresh Ficoll-containing medium from two different reservoirs of a custom-built tonometer. This custom-built system was designed to accommodate a common return, while preventing mixing of perfusate once equilibrated in the two reservoirs. Between the reservoir and the preparation, the central perfusate passed through a bubble trap, heat exchanger and a 25 μm filter. The carotid perfusate passed through a bubble trap and a heat exchanger. Perfusate leaked from the many cut vessels in the preparation and returned to the experimental tonometer where it was recycled and re-equilibrated (total volume of perfusate, 750 ml).
Following the initiation of independent perfusion, the central perfusate was equilibrated with 40 Torr PCO2 in O2, and the peripheral perfusate was equilibrated with 40 Torr PCO2 and 100 Torr PO2 in N2. Over the next 30 min, the temperature of the preparation and the central perfusion pressure was ramped to 32–33°C and ∼90 mmHg, respectively. The central PCO2 was then adjusted slowly to the level utilized for the subsequent protocol (25, 30 or 50 Torr PCO2; estimated pH for 33°C: 7.58, 7.5 and 7.27, respectively). Protocols were started at 70 ± 5 min after central canulation. Gasses used to equilibrate the perfusate were mixed by computer-controlled mass flow controllers (MKS Instruments) and sampled to ensure accuracy (SensorMedics, Medical Gas Analyser LB-2 and Sable Systems PA-1B O2 analyser, calibrated daily). Gas concentrations reported here were accurate to within 0.1% (∼1.3 Torr in Calgary). A neuromuscular blocker was not used.
Electrophysiology
The left phrenic nerve was dissected out with a small piece of diaphragm attached to its distal end, and it was placed in a custom-made plexi-glass recording chamber. The nerve was bathed in perfusate and protected with petroleum jelly. Silver bipolar extracellular electrodes were used to record the phrenic neurogram, which was amplified (A-M Systems Differential AC Amplifier Model 1700), filtered (low cut-off, 300 Hz; high cut-off, 5 KHz), rectified and integrated (Amplitude Demodulator; Saga Tech), computer archived (Axon Instruments Digidata 1322A and Axoscope 9.0) at a sampling rate of 50 Hz, and analysed off-line.
Data analysis
Only preparations that exhibited a ramping phrenic discharge (the peak of phrenic activity occurs in the last 50% of the duty cycle) and an inspiratory time (TI) of ≤1 s under control conditions were included in the study. Preparations with a TI > 1 s were considered apneustic. Analysis of phrenic neurogram characteristics was performed using in-house software written by R.J.A.W. The following respiratory variables were quantified from the integrated phrenic neurogram: period (TTOT), respiratory frequency (fR, 60 times the inverse of the period), time to peak (Tp), inspiratory duration (TI), expiratory duration (TE), neural tidal volume (nVT, the peak phrenic amplitude), neural minute ventilation (nVE, the product of fR and nVT) and eupnoeic index (EI, Tp divided by TI). A schematic of this quantification has been previously published (Day & Wilson, 2005).
Baseline conditions and protocols
Twenty-three preparations were used to quantify the phrenic responses to single or intermittent bouts of specific carotid body hypoxia at various levels of steady-state brainstem PCO2. During the 70 min recovery period, baseline conditions were established: brainstem, 25, 30 or 50 Torr PCO2 in O2; and carotid bodies, 40 Torr PCO2 and 100 Torr PO2 in N2. One of two experimental protocols was superimposed upon these baseline conditions.
Experiment 1: modulation of responses to carotid body hypoxia by brainstem PCO2
This protocol consisted of three phases (15 min each), all identical other than the level of steady-state brainstem PCO2. Protocol: 5 min baseline (brainstem 25 or 50 Torr PCO2, carotid bodies 100 Torr O2, 40 Torr PCO2 in N2), 5 min specific carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2 in N2), 5 min washout (one 15 min phase). A 15 min transition period, equilibrating the brainstem compartment with the alternate level of PCO2 (50 or 25 Torr), preceded initiation of the next phase. The brainstem PCO2 was alternated between 25 and 50 Torr three times, where four animals started and ended with 25 Torr, and four others started and ended with 50 Torr. The total protocol time was 75 min. This protocol design eliminated the possibility of time-dependent effects resulting from repeated carotid body stimulation from contaminating the results. Every phrenic burst over the protocol period was analysed, and respiratory variables were averaged in 30 s bins. Each 15 min phase was cut and grouped together with other matching brainstem CO2 phases. Where an animal experienced a brainstem condition twice, the data were averaged together to contribute one sample. Thus, eight samples were taken from eight animals for each brainstem level. We chose this method of analysis so that (a) no one animal's responses disproportionately weighted the mean, and (b) we were able to utilize a single statistical test (two-factor repeated measures ANOVA) for each respiratory variable (fR, nVT and nVE). To generate a brainstem PCO2 response curve from this data (Fig. 6), baseline phrenic fR, nVT and nVE at 50 Torr PCO2 were normalized to the values obtained at 25 Torr PCO2.
Figure 6.
Proposed theoretical model of the interaction between central and peripheral respiratory chemoreceptors fR, nVT and nVE responses to brainstem PCO2 are data from Experiment 1. Respiratory variables at 50 Torr PCO2 are normalized to the baseline activity when the brainstem was held at 25 Torr PCO2 for each animal. The shape of the central curve is extrapolated from unpublished data (filled symbols; ▪ and •). Open symbols (○ and □) represent the relative responses to specific carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2). Each hypoxic response in A, B and C (○ or □) is from Fig. 3A, B and C, respectively.
Experiment 2: modulation of responses to intermittent carotid body hypoxia by brainstem PCO2
Protocol: 5 min baseline, four 5 min specific carotid body perturbations (60 Torr PO2 and 40 Torr PCO2 in N2), each separated by a 5 min washout, followed by a 30 min recovery period. This protocol was carried out under steady-state brainstem PCO2 of either 30 (n = 9) or 50 Torr (n = 6). The total protocol time was 70 min. Every phrenic burst over the protocol period was analysed, and respiratory variables were averaged in 30 s bins.
Terminology
For statistical tests of respiratory variable dynamics, bins of raw data were selected from each animal as follows: Initial Baseline, minutes 4–5 (two bins) prior to the first perturbation (to which all data were normalized to for graphical presentation); Bout Baseline, the last bin prior to each perturbation (for the first bout, the Bout Baseline is the same as the Initial Baseline); Peak, the highest bin during each perturbation; Trough, the bin with the lowest value (nadir) during each washout. These points were selected for each of the four perturbations. The End Point was taken as an average of the last two bins of each protocol period. These values were selected for fR, nVT and nVE.
Using this nomenclature, we define (a) PHxFD as when the frequency Trough differs from the Initial Baseline, and (b) Delta (Δ) Peak as the difference between Peak and the preceding Initial or Bout Baseline (for fR, nVT and nVE).
Statistical tests
Firstly, we tested for within- and between-group differences in Initial Baseline and End Point variables, for both experiments, using two sets of tests. Two-factor repeated measures (2F RM) ANOVAs were used to test for differences between Initial Baseline and End Point in fR, nVT, nVE, TI, TE and EI and brainstem PCO2 (25 or 50 Torr PCO2) for Experiment 1 data. One-factor (1F) RM ANOVAs were used to test for within-group differences between Initial Baseline and End Point in fR, TI, TE and EI for Experiment 2. 1F ANOVAs were then used to test for between-group differences (brainstem 30 versus 50 Torr PCO2). Data are summarized in Table 1.
Table 1.
Statistical notes
| Note no. | Statistics |
|---|---|
| 1 | Table 2; two-factor (2F) RM ANOVA: Baseline versus End Point for nVT, F = 20.39, P = 0.003. NSD in interaction between brainstem PCO2 and time for nVT (F = 0.53, P = 0.49) |
| 2 | Table 2; 2F RM ANOVA: Brainstem 25 versus 50 Torr PCO2 for Baseline fR (F = 0.034, P = 0.86), nVT (F = 52.94, P < 0.001), nVE (F = 8.47, P = 0.023), TI (F = 10.7, P = 0.014) and EI (F = 11.68, P = 0.011) |
| 3 | Table 3; one-factor (1F) ANOVA: Baseline versus End Point for brainstem 30 Torr PCO2 EI (F = 11.77, P = 0.009) and brainstem 50 Torr PCO2TE (F = 8.12, P = 0.036). Brainstem 30 versus 50 Torr PCO2 for Baseline fR (F = 0.83, P = 0.38) and TI (F = 9.35, P = 0.009) |
| Experiment 1 | |
| 4 | Figs 1B and C, and 2A; 2F RM ANOVA: frequency response (F = 15.33, P = 0.006) |
| 5 | SNK post hoc test: Baseline versus Peak frequency for brainstem 25 Torr PCO2 (q = 7.09, P < 0.001) and 50 Torr PCO2 (q = 2.02, P = 0.18) |
| 6 | Figs 2A and 6A; 2F RM ANOVA: interaction between delta frequency response and brainstem PCO2 (F = 9.93, P = 0.016); SNK post hoc test: comparison between brainstem PCO2 and Peak frequency (q = 3.7, P = 0.025) |
| 7 | Figs 1C and 2A; 1F RM ANOVA: Baseline versus Peak fR under conditions of 50 Torr brainstem PCO2 (F = 14.44, P = 0.007) |
| 8 | Figs 1B and C, and 2B; 2F RM ANOVA: nVT response (F = 11.32, P = 0.012) |
| 9 | SNK post hoc test: Baseline versus Peak nVT for brainstem 25 Torr PCO2 (q = 5.52, P = 0.002) and 50 Torr PCO2 (q = 1.44, P = 0.33) |
| 10 | Figs 2B and 6B; 2F RM ANOVA: interaction between ΔnVT response and brainstem PCO2 (F = 4.46, P = 0.072) |
| 11 | Figs 1C and 2B; 1F RM ANOVA: Baseline versus Peak nVT under conditions of 50 Torr brainstem PCO2 (F = 12.47, P = 0.01) |
| 12 | Figs 1B and C, and 2C; 2F RM ANOVA: nVE response (F = 15.94, P = 0.005) |
| 13 | SNK post hoc test: Baseline versus Peak nVE for brainstem 25 Torr PCO2 (q = 7.47, P < 0.001) and 50 Torr PCO2 (q = 2.49, P = 0.11) |
| 14 | Figs 2C and 6C; 2F RM ANOVA: interaction between ΔnVE response and brainstem PCO2 (F = 13.88, P = 0.007) |
| 15 | Figs 1C and 2C; 1F RM ANOVA: Baseline versus Peak nVE under conditions of 50 Torr brainstem PCO2 (F = 10.234, P = 0.015) |
| Experiment 2 | |
| 16 | Fig. 4A; 1F RM ANOVA: Troughs compared with Initial Baseline and Washout (F = 5.048, P = 0.001) |
| 17 | SNK post hoc test: Troughs compared with Initial Baseline, Trough 1 (q = 3.34, P = 0.059), Trough 2 (q = 4.032, P = 0.033), Trough 3 (q = 4.76, P = 0.014), and Trough 4 (q = 4.923, P = 0.015) |
| 18 | Fig. 4B; 1F RM ANOVA: Troughs compared with Initial Baseline and Washout (F = 3.86, P = 0.01) |
| 19 | SNK post hoc test: Troughs compared with Initial Baseline (q < 1.44, P > 0.85), End point compared with Initial Baseline and Troughs (q > 4.036, P < 0.019) |
| 20 | Fig. 5A, left; 2F RM ANOVA:ΔfR responses for brainstem 30 Torr PCO2 (F = 26.06, P < 0.001), interaction between ΔfR and Bout (F = 6.93, P = 0.002) |
| 21 | Confirmed with 1F RM ANOVA on derived Δ values for fR: SNK post hoc test, pair-wise comparison of Bout 1 with Bouts 2, 3 and 4 (F > 4.58, P < 0.004) |
| 22 | Fig. 5B, left; 2F RM ANOVA: ΔfR responses for brainstem 50 Torr PCO2 (F = 14.79, P = 0.012), interaction between ΔfR and Bout (F = 2.53, P = 0.097) |
| 23 | Fig. 5A, middle; 2F RM ANOVA: ΔnVT responses for brainstem 30 Torr PCO2 (F = 9.63, P = 0.015), interaction between ΔnVT and Bout (F = 0.59, P = 0.63) |
| 24 | Fig. 5B, middle; 2F RM ANOVA: ΔnVT responses for brainstem 50 Torr PCO2 (F = 4.39, P = 0.09), interaction between ΔnVT and Bout (F = 0.53, P = 0.67) |
| 25 | Fig. 5A, right; 2F RM ANOVA: ΔnVE responses for brainstem 30 Torr PCO2 (F = 57.31, P < 0.001), interaction between ΔnVE and Bout (F = 5.91, P = 0.004) |
| 26 | Confirmed with 1F RM ANOVA on derived Δ values for nVE: SNK post hoc test, pair-wise comparison of Bout 1 with Bouts 2, 3 and 4 (F > 4.4, P < 0.008) |
| 27 | Fig. 5B, right; 2F RM ANOVA: ΔnVE responses for brainstem 50 Torr PCO2 (F = 23.94, P = 0.005), interaction between ΔnVE and Bout (F = 1.03, P = 0.41) |
Secondly, for Experiment 1 data, 2F RM ANOVAs were performed to test for the significance of within-delta (Δ) responses in fR, nVT and nVE (two levels: Initial Baseline and Peak variable) and between-group differences (two levels: brainstem 25 versus 50 Torr PCO2).
Thirdly, for Experiment 2 data, 1F RM ANOVAS were used to test for differences in phrenic frequency between the Initial Baseline, End Point and each of the four Troughs for both brainstem conditions (30 and 50 Torr PCO2). Response delta values for Peak fR, nVT and nVE were tested using 2F RM ANOVAs. In these ANOVAs, one factor was the bout (four levels) and the other, the constituent of the delta values (two levels, Bout Baseline and Peak variable during carotid body hypoxic bout).
Statistical tests were performed on raw data. In all cases, once significant differences had been determined (assumed at P < 0.05), Student-Newman-Keuls (SNK) post hoc tests were used for pair-wise comparisons.
Results
Baseline variables and stability
The Initial Baseline (the last minute of the baseline period) and End Point (the last minute of the protocol, i.e. washout) for fR, nVT, nVE, TI, TE and EI were compared to assess these respiratory variables under different brainstem conditions (summarized in Tables 2 and 3) for both experimental protocols.
Table 2.
Raw data from Initial Baseline and End Points under different steady-state brainstem PCO2 conditions from Experiment 1, Single Bout CB Hypoxia Within Animal
| Respiratory variable | Baseline | End Point |
|---|---|---|
| 25 Torr PCO2 brainstem = 8 | ||
| fR (min−1) | 30.87 ± 4.4 | 32.04 ± 4.82 |
| nVT (a.u.) | 3.5 ± 0.32 | 3.29 ± 0.28*1 |
| nVE (a.u.) | 109.24 ± 17.47 | 103.91 ± 15.77 |
| TI (s) | 0.97 ± 0.066 | 0.99 ± 0.089 |
| TE (s) | 1.49 ± 0.52 | 1.81 ± 0.93 |
| EI | 0.67 ± 0.24 | 0.68 ± 0.24 |
| 50 Torr PCO2 brainstem n = 8 | ||
| fR (min−1) | 31.7 ± 2.012 | 32.39 ± 1.88 |
| nVT (a.u.) | 4.42 ± 0.24+,2 | 4.27 ± 0.24*1 |
| nVE (a.u.) | 140.81 ± 13.23+2 | 139.61 ± 13.54 |
| TI (s) | 0.73 ± 0.072+2 | 0.73 ± 0.067 |
| TE (s) | 1.23 ± 0.14 | 1.18 ± 0.12 |
| EI | 0.60 ± 0.036+2 | 0.58 ± 0.033 |
a.u., arbitrary units; TI, inspiratory duration; TE, expiratory duration; EI, eupnoeic index. These data illustrate the phrenic neurogram characteristics during the baseline period prior to and during a washout period following the experimental perturbation. Note that the baseline frequency is no different under any brainstem PCO2 condition.
End Point variable is significantly different than the same variable for Baseline.
Variable at 50 Torr PCO2 brainstem is significantly different than the same variable under conditions of 25 Torr PCO2 brainstem.
Table 3.
Raw data from Initial Baseline and End Points under different steady-state brainstem PCO2 conditions from Experiment 2, Intermittent Hypoxia
| Respiratory variable | Baseline | End Point |
|---|---|---|
| 30 Torr PCO2 brainstem n = 9 | ||
| fR (min−1) | 33.42 ± 3.31 | 33.31 ± 4.52 |
| TI (s) | 0.81 ± 0.05 | 0.88 ± 0.06 |
| TE (s) | 1.19 ± 0.26 | 1.58 ± 0.6 |
| EI | 0.72 ± 0.027 | 0.76 ± 0.031*,3 |
| 50 Torr PCO2 brainstem n = 6 | ||
| fR (min−1) | 29.43 ± 1.73 | 31.53 ± 2.33 |
| TI (s) | 0.59 ± 0.05+,3 | 0.61 ± 0.034 |
| TE (s) | 1.51 ± 0.164 | 1.37 ± 0.17*,3 |
| EI | 0.72 ± 0.019 | 0.74 ± 0.012 |
These data illustrate the phrenic neurogram characteristics during the baseline period prior to and during a washout period following the experimental perturbation. Note that the baseline frequency is no different under any brainstem PCO2 condition.
End Point variable is significantly different than the same variable for Baseline.
Variable at 50 Torr PCO2 brainstem is significantly different than the same variable under conditions of 30 Torr PCO2 brainstem. nVT and nVE were not compared because these values contain arbitrary units (a.u.) and these two data sets are from different animals.
For Experiment 1, there were no differences between most Baseline and End Point respiratory variables for both brainstem conditions (25 and 50 Torr PCO2). However, when comparing Baseline and End Point nVT for both brainstem conditions, there was a decline over time (P = 0.003, Table 11). When comparing Baseline between brainstem conditions (a) baseline fR was no different (P = 0.86, Table 12), (b) nVT was different (P < 0.001, Table 12), and (c) nVE was different (P = 0.023, Table 12).
For Experiment 2, fR, TI, TE and EI were similarly tested. There were no differences between most Baseline and End Point respiratory variables for both brainstem conditions (30 and 50 Torr PCO2). Of note, when comparing Baseline between brainstem conditions, baseline fR was no different (P = 0.38, Table 13).
The variables of TI, TE and EI are reported in Tables 2 and 3 as indices of the shape of the neurogram and to ensure that the preparations used in the study fit the inclusion criteria. Preparations were included if they maintained a TI≤ 1 s and EI between 0.5 and 1, indicating the peak of the neurogram occurred late in the duty cycle.
Experiment 1: modulation of responses to carotid body hypoxia by brainstem PCO2
In Experiment 1, each preparation experienced each brainstem condition (25 and 50 Torr PCO2) at least once (four preparations experienced 25 Torr twice and the other four experienced 50 Torr twice). Under each of these brainstem conditions, preparations experienced one bout of specific carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2). Figures 1 and 2 illustrate fR, nVT and nVE responses.
Figure 1.
Time course of respiratory variables in response to specific carotid body hypoxia (60 TorrPO2and 40 TorrPCO2) under differing steady-state brainstemPCO2(Experiment 1) A, sample rectified, integrated neurogram of one entire experimental protocol whereby each animal experienced both brainstem PCO2 levels shown. Total protocol time is 75 min. B and C, combined mean respiratory frequency (fR), neural tidal volume (nVT) and neural minute ventilation (nVE) responses to carotid body hypoxia when the brainstem was held at steady-state 25 Torr PCO2 and 50 Torr PCO2, respectively. Data represent eight samples from eight animals. Bins represent 30 s averages of the respiratory variable shown. Black bars represent hypoxic carotid body stimulation (5 min). Total time is 15 min. Error bars represent s.e.m. Data are normalized to last minute of the baseline immediately preceding the hypoxic challenge.
Figure 2.
Respiratory responses (normalized to Initial Baseline) to specific carotid body hypoxia under conditions of 25 and 50 Torr steady-state brainstemPCO2 A, fR; B, nVT; C, nVE. *Response is significantly different from baseline. +Response is significantly different from 25 Torr PCO2 brainstem (i.e. interaction). Data are from eight samples (at each brainstem PCO2 level) taken from eight animals. Error bars represent s.e.m.
fR responses
Figure 2A illustrates the quantification of fR responses to carotid body hypoxia under conditions of brainstem PCO2 of 25 and 50 Torr PCO2. Carotid body hypoxia elicited a frequency response (Peak fR compared to Baseline; P = 0.006, Table 14). Under conditions of 25 Torr brainstem, there was a frequency response, whereas under conditions of 50 Torr, there was not (P < 0.001 (Table 15) and P = 0.18 (Table 15), respectively). Thus, there was an interaction between brainstem PCO2 and the delta response for frequency (P = 0.016, Table 16). Although the 2F RM ANOVA revealed no fR response under conditions of 50 Torr brainstem (Figs 1C and 2A), a 1F RM ANOVA on this data set revealed a statistically significant response (P = 0.007, Table 17).
nVT responses
Figure 2B illustrates the quantification of nVT responses to carotid body hypoxia under conditions of brainstem PCO2 of 25 and 50 Torr PCO2. Carotid body hypoxia elicited an nVT response (Peak nVT compared with Baseline; P = 0.012, Table 18). Under conditions of 25 Torr brainstem, there was an nVT response, whereas under conditions of 50 Torr, there was not (P = 0.002 (Table 19) and P = 0.33 (Table 19), respectively). Thus, although an interaction between brainstem PCO2 and the delta response for nVT was not significant, the similarity was weak (P = 0.072, Table 110). Although the 2F RM ANOVA revealed no nVT response under conditions of 50 Torr brainstem (Figs 1C and 2B), a 1F RM ANOVA on this data set revealed a statistically significant response (P = 0.01, Table 111).
nVE responses
Figure 2C illustrates the quantification of nVE responses to carotid body hypoxia under conditions of brainstem PCO2 of 25 and 50 Torr PCO2. Carotid body hypoxia elicited an nVE response (Peak nVE compared to Initial Baseline; P = 0.005, Table 112). Under conditions of 25 Torr brainstem, there was a frequency response, whereas under conditions of 50 Torr, there was not (P < 0.001 (Table 113) and P = 0.11 (Table 113), respectively). Thus, there was an interaction between brainstem PCO2 and the delta response for nVE (P = 0.007, Table 114). Although the 2F RM ANOVA revealed no nVE response under conditions of 50 Torr brainstem (Figs 1C and 2C), a 1F RM ANOVA on this data set revealed a statistically significant response (P = 0.015, Table 115).
Experiment 2: modulation of responses to intermittent carotid body hypoxia by brainstem PCO2
In Experiment 2, under steady-state brainstem conditions of either 30 or 50 Torr PCO2, preparations experienced four bouts of 5 min specific carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2), separated by 5 min and followed by a 30 min washout. Figures 3, 4 and 5 illustrate fR, nVT and nVE responses.
Figure 3.
Time course of respiratory variables during intermittent specific carotid body hypoxia (60 TorrPO2) under differing steady-state brainstemPCO2(Experiment 2) A, fR, nVT and nVE when the brainstem was held at 30 Torr PCO2 (n = 9). B, fR, nVT and nVE when the brainstem was held at 50 Torr PCO2 (n = 6). Bins represent 30 s averages of variables shown. Black bars represent hypoxic carotid body stimulation (5 min). Total protocol time is 70 min. Error bars are s.e.m. Data are normalized to a 1 min baseline prior to the first perturbation.
Figure 4.
Post-hypoxia responses (normalized to Initial Baseline) in frequency (fR) to specific carotid body hypoxia (60 TorrPO2and 40 TorrPCO2) under conditions of steady-state 30 (n = 9) or 50 Torr (n = 6)PCO2brainstem A, post-hypoxia fR Trough where the brainstem was held at 30 Torr PCO2. B, post-hypoxia fR Trough where the brainstem was held at 50 Torr PCO2. The post-hypoxic Trough represents the lowest 30 s fR bin (nadir) following each bout of hypoxia during each 5 min washout. Where the Trough is significantly different than the initial baseline, post-hypoxic frequency decline (PHxFD) is present. Data are normalized to the last minute of the initial baseline period. Error bars represent s.e.m.*Significantly different than the initial baseline.
Figure 5.
Delta (Δ) responses (relative to each bout baseline) to intermittent carotid body hypoxia under differing steady-state brainstemPCO2conditions A, ΔfR, ΔnVT and ΔnVE when the brainstem was held at 30 Torr PCO2. B, ΔfR, ΔnVT and ΔnVE when the brainstem was held at 50 Torr PCO2. Data are normalized to the last minute of the initial baseline period. Error bars are s.e.m.*Peak is significantly different from each respective bout baseline. +Delta response is significantly different from the first response, demonstrating progressive augmentation.
fR responses
Figure 4A and B illustrates the quantification of posthypoxic responses to specific carotid body intermittent hypoxia under conditions of 30 and 50 Torr brainstem PCO2. For steady-state brainstem 30 Torr PCO2, following termination of hypoxic bouts the activity between bouts decreased below the initial baseline (i.e. PHxFD, Troughs compared with Initial Baseline and End Point; P = 0.001, Table 116). PHxFD appeared to have some bout dependence, as Troughs 2, 3 and 4 were significantly different than baseline whereas Trough 1 was not (Trough for bouts 1, 2, 3 and 4: P = 0.059, P = 0.033, P = 0.014 and P = 0.015, respectively, Table 117). Conversely, for steady-state brainstem 50 Torr PCO2, following termination of hypoxic bouts, the activity between bouts did not decrease below baseline (Troughs compared to Initial Baseline and End Point; P > 0.85, Table 118,19).
The left-hand panels of Fig. 5A and B illustrate the quantification of delta (Δ) fR responses to specific carotid body intermittent hypoxia under conditions of 30 and 50 Torr brainstem PCO2. For steady-state brainstem 30 Torr PCO2, each of the four hypoxic bouts elicited increases in fR that were bout dependent (ΔfR responses, P < 0.001, Table 120; interaction between ΔfR and bout, P = 0.002, Table 120). Thus, the ΔPeak fR from each bout baseline got progressively larger with each bout, where the derived delta values from bouts 2, 3 and 4 were larger than bout 1 (P < 0.004, Table 121). For steady-state brainstem 50 Torr PCO2, each of the four hypoxic bouts elicited increases in fR that were not bout dependent (ΔfR responses, P = 0.012, Table 122; interaction between ΔfR and bout, P = 0.097, Table 122).
nVT responses
The middle panels of Fig. 5A and B illustrate the quantification of ΔnVT responses to specific carotid body intermittent hypoxia under conditions of 30 and 50 Torr brainstem PCO2. For steady-state brainstem 30 Torr PCO2, each of the four hypoxic bouts elicited increases in nVT that were not bout dependent (ΔnVT responses, P = 0.015, Table 123; interaction between ΔnVT and bout, P = 0.63, Table 123). For steady-state brainstem 50 Torr PCO2, none of the four hypoxic bouts elicited significant increases in nVT (ΔnVT responses, P = 0.090, Table 124).
nVE responses
The right-hand panels of Fig. 5A and B illustrate the quantification of ΔnVE responses to specific carotid body intermittent hypoxia under conditions of 30 and 50 Torr brainstem PCO2. For steady-state brainstem 30 Torr PCO2, each of the four hypoxic bouts elicited increases in nVE that were bout dependent (ΔnVE responses, P < 0.001, Table 125; interaction between ΔnVE and bout, P = 0.004, Table 125). Thus, the ΔPeak nVE from each bout baseline got progressively larger with each bout, where bouts 2, 3 and 4 were larger than bout 1 (P < 0.008, Table 126). For steady-state brainstem 50 Torr PCO2, each of the four hypoxic bouts elicited increases in nVE that were not bout dependent (ΔnVE responses, P = 0.005, Table 127; interaction between ΔnVE and bout, P = 0.41, Table 127).
Discussion
Using an in situ DPP, we report that the level of steady-state brainstem PCO2 modulates the magnitude of (a) phrenic responses resulting from specific carotid body hypoxia (60 Torr PO2 and 40 Torr PCO2), and (b) time-dependent phenomena. Numerous studies have examined the interaction of central and peripheral chemoreceptors previously. However, ours is the first study to separate central and peripheral chemosensitivity in the rat and explore how the interaction of chemoreceptors without vagal or cortical descending inputs affects time-dependent ventilatory phenomena.
The DPP: a model for studying chemoreceptor interactions in the rat
The DPP provides a novel method for studying respiratory chemoreceptor interaction in the rat. Uniquely, the DPP allows the study of respiratory chemosensitivity in non-anaesthetized decerebrate rodents, independent of heart rate, systemic blood pressure, hormonal factors and vagal inputs. As such, the DPP provides an important bridge between studies of central and peripheral respiratory chemosensitivity at the system level and recent studies in rodents at the cellular level (Mulkey et al. 2004; Takakura et al. 2006).
The main limitations of the DPP are shared with other decerebrate and vagotomized preparations. Particularly, there is a pronounced leftward shift of the apnoeic threshold and the CO2 responsiveness relative to intact animals (compare Boden et al. 1998 with Day & Wilson, 2005). Other studies have demonstrated that both decerebration (Hayashi & Sinclair, 1991; Mitchell, 1990; Nielsen et al. 1986; St-John & Paton, 2000) and vagotomy (Takakura et al. 2006) can shift chemosensitivity in the hypocapnic direction. This consistent observation is an important caveat to consider when interpreting data from studies of chemosensitivity using decerebrate and vagotomized preparations.
An additional caveat to consider is that the artificially perfused brainstem of the DPP is likely to be hyperoxic (Tissue PO2, ∼200 Torr; Wilson et al. 2001). To date, we have been unable to demonstrate that hyperoxia affects the output of the DPP, although such a possibility cannot be excluded.
Like anaesthesia, decerebration eliminates cortical inputs influencing respiration, but without the chemical desensitizing effects of anaesthesia on chemosensitivity (Czapla & Zadina, 2005). The CO2 chemosensitivity of this preparation is similar in magnitude to that reported in awake freely behaving rats of the same species (compare Czapla & Zadina, 2005 with Day & Wilson, 2005). Further, the removal of descending influences by decerebration provides a level of reduction that is likely to be essential toward understanding the complexity of chemoreceptor interactions without the confounding influences of wakefulness drive on ventilation (Fink, 1961).
Finally, an important strength of our model is that both central and peripheral chemoreceptor compartments are intact and independently perfused artificially. Unlike in vivo breathing preparations, we can hold the brainstem with levels of PCO2 below eupnoeic levels. Thus, the role of one chemoreceptor can be explored across the entire physiological range while the other chemoreceptor is maintained at steady-state levels of chemostimulation.
Hypo-additive interaction between peripheral and central chemoreceptors
In the DPP, peripheral chemoreceptor stimulation had little effect on nVT; nVT was largely dictated by the level of brainstem PCO2 (Fig. 6B). In contrast, increasing brainstem PCO2 from 25 to 50 Torr, while maintaining normoxic and normocapnic carotid body perfusion, had little effect on frequency; changes in frequency were largely brought about by changes in carotid body PO2 (Figs 1B and C, 2A and 6A).
As peripheral chemoreceptor stimulation had little effect on nVT, the interaction between central and peripheral chemoreceptors in terms of nVT is best described as additive. Remarkably, however, frequency responses were greatest when peripheral chemoreceptors were stimulated while the brainstem was hypocapnic (increased ∼50% above that without peripheral stimulation; Figs 2A and 6A). When both peripheral and central chemoreceptors were stimulated (carotid body hypoxia and brainstem 50 Torr PCO2), mean frequency was elevated only slightly above that without peripheral stimulation (∼10%; Figs 2A and 6A). Thus, central chemoreceptor activation appears to clamp respiratory frequency, nullifying the effect of excitatory inputs from peripheral chemoreceptors. In terms of frequency then, the interaction between central and peripheral chemoreceptors is strongly hypo-additive.
The combined effect of additive nVT and hypo-additive frequency interactions is a hypo-additive nVE interaction. Specifically, carotid body hypoxia induced a large increase in nVE when brainstem PCO2 was low (∼70%), but only a minimal increase in nVE when brainstem PCO2 was high (∼10%; Figs 2C and 6C).
Other investigators have demonstrated hypo-additive VE interactions in larger mammals, including awake goats (Smith et al. 1984), anaesthetized dogs (Gesell et al. 1940; Adams & Severns, 1982) and cats (Berger et al. 1978; Giese et al. 1978; Eldridge et al. 1981). For example, Adams & Severns (1982) used specific carotid body perfusion with either normoxic or hypoxic–hypercapnic blood in anaesthetized dogs breathing various levels of inspired CO2 in order to maintain systemic (central) isocapnia. They found that specific carotid body stimulation produced significant increases in tidal volume when systemic PaCO2 was normocapnic but not hypercapnic. Respiratory frequency continued to increase with carotid body stimulation at all levels of systemic PaCO2. The model used by these investigators only allows changes in systemic PCO2 in the hypercapnic direction. Smith et al. (1984) investigated the ventilatory responses to carotid body stimulation across a wider range of cerebral spinal fluid (CSF) pH in awake goats by perfusing the cisterna magna artificially with mock CSF containing varying levels of bicarbonate. Employing bolus intravenous injections of NaCN to stimulate the carotid bodies, they found that carotid body stimulation was more efficacious at eliciting increases in tidal volume and breathing frequency when the cisterna magna perfusion was alkaline than acidic (Smith et al. 1984).
However, other studies have found qualitatively different results. For example, simple addition in VE has been reported in awake goats (Daristotle & Bisgard, 1989), pons-medulla artificially perfused anaesthetized cats (Heeringa et al. 1979; van Beek et al. 1983) and humans (Clement et al. 1992, 1995; St. Croix et al. 1996). Moreover, simple addition between inputs is assumed in models of the human respiratory system (Khoo et al. 1991; Painter et al. 1993; Ursino et al. 2001; Duffin & Mahamed, 2003; Topor et al. 2004).
An additive interaction in VE necessitates a hypo-additive interaction in at least one respiratory variable due to the multiplicative relationship between tidal volume and rate in generating minute ventilation (Mitchell et al. 1990). Thus, a number of discrepant reports may be reconciled to some degree by considering volume and timing components separately. Unfortunately, several of these interaction studies suggesting simple addition report only VE (Heeringa et al. 1979, Van Beek et al. 1983; Clement et al. 1992, 1995; St Croix et al. 1996) or could not discriminate underlying hypo-additive interactions in volume or frequency when data from multiple animals were combined (e.g. Daristotle & Bisgard, 1989).
Our findings are in contrast to other studies in intact humans (Robbins, 1988) and anaesthetized dogs (Adams et al. 1978) that suggest the interaction is hyper-additive. However, we note that studies in humans have reported both hyper-additive interaction and simple addition (compare Robbins, 1988 with Clement et al. 1992, 1995, and St Croix et al. 1996). Similarly, whereas Adams et al. (1978) report a hyper-additive interaction in dogs, other studies in dogs report hypo-additive interactions (Gesell et al. 1940; Adams & Severns, 1982). Further, we note that studies in humans assume that the contribution of central and peripheral chemoreceptors in stimulating ventilation can be temporally separated by exploiting the difference in time constants between the responses from stimulation of the two receptor sites (e.g. DeGoede et al. 1985; Pedersen et al. 1999). This assumption may be only partly correct given work in humans where the central chemoreceptor gain (determined via temporal separation technique) is decreased when the carotid body input is eliminated by resection (Bellville et al. 1979; Fatemian et al. 2003). Finally, in vivo studies of chemoreceptor interaction necessitate measurements in the presence of vagal and descending cortical inputs. These influences may themselves interact with central and peripheral chemoreceptors, causing an apparent change in the algebra of peripheral and central chemoresponses.
Our results also differ, at least superficially, from recent cellular work suggesting simple addition between the CO2 response of putative central respiratory chemoreceptor cells in the retrotrapezoid nucleus (RTN) and carotid body stimulation (Takakura et al. 2006). These authors suggest that carotid body stimulation increases RTN cell firing rates across a range of inspired CO2 (above eupnoeic levels) in an additive manor; however, in this study: (a) recordings were made from single cells from only one of several putative central chemoreceptor sites; and (b) in the protocol, both chemoreceptor compartments were stimulated when systemic CO2 was increased. The known multiplicative interaction between O2 and CO2 at the level of the carotid body is likely to confound these results.
In summary, the various experimental models, techniques and designs may contribute to the discrepant literature on central–peripheral chemoreceptor interaction. However, we note that in all but one study (Adams et al. 1978) in which stimuli to the central and peripheral chemoreceptors were physically separated, hypo-additivity has either been explicitly documented or is necessarily present algebraically, albeit in different respiratory variables, depending on the species.
Brainstem PCO2 modulates time-dependent effects
Importantly, our data also suggest that central chemoreceptor activation can nullify time-dependent ventilatory phenomena produced by episodic activation of the peripheral chemoreceptors.
In Experiment 2 we examined the effects of differing steady-state brainstem PCO2 on the phrenic responses resulting from specific carotid body intermittent hypoxia. Previously, we showed that specific carotid body hypoxia (40 Torr PO2, 40 Torr PCO2 balanced N2) is sufficient to elicit PHxFD under conditions of 30 Torr steady-state brainstem PCO2. Repeated hypoxic bouts exacerbate PHxFD, leading to larger response deltas for each subsequent bout of hypoxia (progressive augmentation). The progressive augmentation in frequency translated into nVE (Day & Wilson, 2005). Here we demonstrate that a milder hypoxic stimulus (60 Torr PO2) was also sufficient to elicit post-hypoxic frequency decline and progressive augmentation (in both fR and nVE) under the same brainstem conditions as the previous study, although it took two bouts to get a significant post-hypoxic depression (Fig. 4A). However, when the brainstem was held at 50 Torr PCO2, PHxFD and progressive augmentation were absent, even after four bouts of carotid body hypoxia (Figs 3B, 4B and 5B).
The magnitude of other time-dependent effects may also depend on brainstem PCO2. For example, Eldridge (1974) demonstrated that ventilatory after-discharge, defined as a sustained increase in ventilation following termination of stimulus, appears to be masked by hypercapnia (∼10 Torr above the apnoeic threshold). However, another study reported that ventilatory after-discharge is prolonged under conditions of systemic hypercapnia and truncated under conditions of poikilocapnia (lowered systemic PCO2; Engwall et al. 1994). Neither study specifically address post-hypoxic frequency decline.
Several studies have demonstrated the importance of the noradrenergic A5 pontine region in PHxFD. Lesions to this region abolishes PHxFD in both the anaesthetized, artificially ventilated and intact awake rat (Coles & Dick, 1996; Schlenker & Prestbo, 2003), while electrical stimulation of this region causes prolongation of TE. Further, systemic application of α-adrenoreceptor antagonists blocks PHxFD, although whether this is through a central or peripheral mechanism is currently unclear (Coles et al. 1998; Bach et al. 1999). Recent work suggests that the A5 region may contain neurons that have an endogenous sensitivity to hypercapnia (Ilyinsky et al. 2003). The A5 region is also stimulated by carotid sinus nerve activation (Guyenet et al. 1993; Erickson & Millhorn, 1994). Thus, this region may be an integration site for PHxFD, responding to specific carotid body hypoxia and modulated by hypercapnia.
Interaction versus saturation
Given the shift in the chemosensitive range of decerebrate preparations like the DPP, the possibility exists that the increase in ventilation produced by activation of central chemoreceptors might mask the effects of activating the peripheral chemoreceptors through saturation of a common pathway within the CNS (Eldridge et al. 1981; Smith et al. 1984). However, this saturation hypothesis does not appear to hold in the case of frequency, because (a) baseline frequencies are the same at both levels of brainstem PCO2 (Table 2 and Fig. 6A), and (b) carotid body stimulation often elicited larger absolute maximum values when the brainstem was 25 Torr PCO2 than when it was 50 Torr PCO2, in the same animal (Fig. 6A).
Significance
Our data demonstrate that in the rat, when central and peripheral chemoreceptor compartments are perfused independently, the contribution of the carotid bodies to ventilation is largely dictated by the chemical status of the central compartment. Thus, despite the caveats of our preparation, our data are in agreement with all but one animal study in which the two compartments have been stimulated independently, confirming a negative interaction in at least one component of the ventilatory response. Hence, a negative interaction has been reliably demonstrated across species, and calls into question the validity of the assumption of simple addition used in models of the human respiratory controller.
We hypothesize that the negative interaction between the chemoreceptor compartments may be important in the pathophysiology of periodic breathing. In vivo, the central chemoreceptors are likely to be protected from rapid changes in blood gases by the temporal delay in CO2 transit and equilibration in the central compartment (Pedersen et al. 1999; Teppema & Dahan, 2005; Smith et al. 2006). Consequently, conditions may arise in which activation of peripheral chemoreceptors occurs during chronic central hypocapnia. Our results suggest that in situations where the brainstem is hypocapnic, an augmented peripheral chemoreflex may result, compared with when the brainstem is normocapnic. An increase in peripheral chemoreflex gain has the potential to exacerbate the likelihood of periodic breathing during sleep (Chapman et al. 1988; Topor et al. 2004), when the sole reliance is on the chemical control system (Skatrud & Dempsey, 1983). In this regard, we note clinical observations that congestive heart failure patients (Xie et al. 1995; Solin et al. 2000) and those sleeping at high altitude (Lahiri et al. 1983; Burgess et al. 2004) have increased peripheral chemoreflex gain and periodic breathing during sleep in the face of chronic hyperpnoea and hypocapnia.
Conclusions
In conclusion, our data suggest a negative (i.e. hypo-additive) interaction exists between central and peripheral respiratory chemoreceptors in the rat, supporting data from studies in larger animals, but in contrast to models used for the human respiratory control system. We also demonstrated that PHxFD and progressive augmentation resulting from intermittent carotid body hypoxia can be modulated by the level of brainstem PCO2. These results suggest that in clinical populations experiencing sustained hyperpnoea, the resulting brainstem hypocapnia may increase the gain of the peripheral chemoreflex, potentially exacerbating the likelihood of periodic breathing during sleep.
Acknowledgments
We gratefully acknowledge: (a) salary support for R.J.A.W. from the AHFMR and the CIHR/Rx & D Focus on Stroke Partnership Award in Health Research Program (sponsored jointly by HSF, Canadian Stroke Network, CIHR and AstraZeneca); (b) salary support for T.A.D. from a CIHR Doctoral Award; and (c) operating grants from the following Canadian funding agencies: AHFMR, CIHR and NSERC.
References
- Adams JM, Attinger FM, Attinger EO. Medullary and carotid chemoreceptor interaction for mild stimuli. Pflugers Arch. 1978;374:39–45. doi: 10.1007/BF00585695. [DOI] [PubMed] [Google Scholar]
- Adams JM, Severns ML. Interaction of chemoreceptor effects and its dependence on the intensity of stimuli. J Appl Physiol. 1982;52:602–606. doi: 10.1152/jappl.1982.52.3.602. [DOI] [PubMed] [Google Scholar]
- Bach KA, Kinkead R, Mitchell GS. Post-hypoxia frequency decline in rats: sensitivity to repeated hypoxia and α2-adrenoreceptor antagonism. Brain Res. 1999;817:25–33. doi: 10.1016/s0006-8993(98)01181-0. [DOI] [PubMed] [Google Scholar]
- Baker TL, Mitchell GS. Episodic but not continuous hypoxia elicits long-term facilitation of phrenic motor output in rats. J Physiol. 2000;529:215–219. doi: 10.1111/j.1469-7793.2000.00215.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Beek JH, Berkenbosch A, de Goede J, Olievier CN. Influence of peripheral O2 tension on the ventilatory response to CO2 in cats. Respir Physiol. 1983;51:379–390. doi: 10.1016/0034-5687(83)90030-0. [DOI] [PubMed] [Google Scholar]
- Bellville JW, Whipp BJ, Kaufman RD, Swanson GD, Aqleh KA, Wiberg DM. Central and peripheral chemoreflex loop gain in normal and carotid body-resected subjects. J Appl Physiol. 1979;46:843–853. doi: 10.1152/jappl.1979.46.4.843. [DOI] [PubMed] [Google Scholar]
- Berger W, Berger K, Berndt J, Giese K. Interaction of peripheral and central respiratory drives in cats. I. Effects of sodium cyanide as a peripheral chemoreceptor stimulus at different levels of CSF pH. Pflugers Arch. 1978;374:205–210. doi: 10.1007/BF00585596. [DOI] [PubMed] [Google Scholar]
- Boden AG, Harris MC, Parkes MJ. Apnoeic threshold for CO2 in the anaesthetized rat: fundamental properties under steady-state conditions. J Appl Physiol. 1998;85:898–907. doi: 10.1152/jappl.1998.85.3.898. [DOI] [PubMed] [Google Scholar]
- Burgess KR, Johnson PL, Edwards N. Central and obstructive sleep apnoea during ascent to high altitude. Respirology. 2004;9:222–229. doi: 10.1111/j.1440-1843.2004.00576.x. [DOI] [PubMed] [Google Scholar]
- Chapman KR, Bruce EN, Gothe B, Cherniack NS. Possible mechanisms of periodic breathing during sleep. J Appl Physiol. 1988;64:1000–1008. doi: 10.1152/jappl.1988.64.3.1000. [DOI] [PubMed] [Google Scholar]
- Clement ID, Bascom DA, Conway J, Dorrington KL, O'Connor DF, Painter R, Paterson DJ, Robbins PA. An assessment of central–peripheral ventilatory chemoreflex interaction in humans. Respir Physiol. 1992;88:87–100. doi: 10.1016/0034-5687(92)90031-q. [DOI] [PubMed] [Google Scholar]
- Clement ID, Pandit JJ, Bascom DA, Dorrington KL, O'Connor DF, Robbins PA. An assessment of central–peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans. J Physiol. 1995;485:561–570. doi: 10.1113/jphysiol.1995.sp020752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coles SK, Dick TE. Neurones in the ventrolateral pons are required for post-hypoxic frequency decline in rats. J Physiol. 1996;497:79–94. doi: 10.1113/jphysiol.1996.sp021751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coles SK, Ernsbereger P, Dick TE. Post-hypoxic frequency decline does not depend on α-adrenergic receptors in the adult rat. Brain Res. 1998;794:267–273. doi: 10.1016/s0006-8993(98)00234-0. [DOI] [PubMed] [Google Scholar]
- Cunningham DJC, Robbins PA, Wolff CB. Integration of respiratory responses to changes in alveolar partial pressures of CO2 and O2 and in arterial pH. In: Fishman AP, Cherniack NS, Widdicombe JG, editors. Handbook of Physiology. vol. II. Bethesda, MD, USA: American Physiological Society; 1986. pp. 475–528. section 3, The Respiratory System. [Google Scholar]
- Czapla MA, Zadina JE. Reduced suppression of CO2-induced ventilatory stimulation by endomorphines relative to morphine. Brain Res. 2005;1059:159–166. doi: 10.1016/j.brainres.2005.08.020. [DOI] [PubMed] [Google Scholar]
- Daristotle L, Bisgard G. Central–peripheral chemoreceptor ventilatory interaction in awake goats. Respir Physiol. 1989;76:383–392. doi: 10.1016/0034-5687(89)90078-9. [DOI] [PubMed] [Google Scholar]
- Day TA, Wilson RJ. Specific carotid body chemostimulation is sufficient to elicit phrenic post-stimulus frequency decline in a novel in situ dual perfused rat preparation. Am J Physiol Regul Integr Comp Physiol. 2005;289:R532–R544. doi: 10.1152/ajpregu.00812.2004. [DOI] [PubMed] [Google Scholar]
- DeGoede J, Berkenbosch A, Denham WS, Bellville JW, Olievier CN. Comparison of chemoreflex gains obtained with two different methods in cats. J Appl Physiol. 1985;59:170–179. doi: 10.1152/jappl.1985.59.1.170. [DOI] [PubMed] [Google Scholar]
- Dick TE, Coles SK. Ventrolateral pons mediates short-term depression of respiratory frequency after brief hypoxia. Respir Physiol. 2000;121:87–100. doi: 10.1016/s0034-5687(00)00121-3. [DOI] [PubMed] [Google Scholar]
- Duffin J, Mahamed S. Adaptation in the respiratory control system. Can J Physiol Pharmacol. 2003;81:765–773. doi: 10.1139/y03-049. [DOI] [PubMed] [Google Scholar]
- Eldridge FL. Central neural stimulatory effect of active respiration. J Appl Physiol. 1974;37:723–735. doi: 10.1152/jappl.1974.37.5.723. [DOI] [PubMed] [Google Scholar]
- Eldridge FL, Gill-Kumar P, Millhorn DE. Input–output relationships of central neural circuits involved in respiration in cats. J Physiol. 1981;311:81–95. doi: 10.1113/jphysiol.1981.sp013574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eldridge FL, Millhorn DE. Oscillation, gating and memory in the respiratory control system. In: Cherniak NS, Widdicombe JG, editors. Handbook of Physiology. vol. II. Bethesda, MD, USA: American Physiological Society; 1986. pp. 93–114. section 3, The Respiratory Control System, Control of Breathing. [Google Scholar]
- Engwall MJA, Daristotle L, Niu WZ, Dempsey JA, Bisgard GE. Ventilatory afterdischarge in the awake goat. J Appl Physiol. 1991;71:1511–1517. doi: 10.1152/jappl.1991.71.4.1511. [DOI] [PubMed] [Google Scholar]
- Engwall MJA, Smith CA, Dempsey JA, Bisgard GE. Ventilatory afterdischarge and central respiratory drive interactions in the awake goat. J Appl Physiol. 1994;76:416–423. doi: 10.1152/jappl.1994.76.1.416. [DOI] [PubMed] [Google Scholar]
- Erickson JT, Millhorn DE. Hypoxia and electrical stimulation of the carotid sinus nerve induce Fos-like immunoreactivity within catecholaminergic and serotoninergic neurons of the rat brainstem. J Comp Neurol. 1994;348:161–182. doi: 10.1002/cne.903480202. [DOI] [PubMed] [Google Scholar]
- Fatemian M, Nieuwenhuijs DJ, Teppema LJ, Meinesz S, van der Mey AG, Dahan A, Robbins PA. The respiratory response to carbon dioxide in humans with unilateral and bilateral resections of the carotid bodies. J Physiol. 2003;549:965–973. doi: 10.1113/jphysiol.2003.042259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fink BR. Influence of cerebral activity in wakefulness on regulation of breathing. J Appl Physiol. 1961;16:15–20. doi: 10.1152/jappl.1961.16.1.15. [DOI] [PubMed] [Google Scholar]
- Fregosi RF, Mitchell GS. Long-term facilitation of inspiratory intercostal nerve activity following carotid sinus nerve stimulation in cats. J Physiol. 1994;477:469–479. doi: 10.1113/jphysiol.1994.sp020208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gesell R, Lapides J, Levin M. The interaction of central and peripheral chemical control of breathing. Am J Physiol. 1940;130:155–170. [Google Scholar]
- Giese K, Berndt J, Berger W. Interaction of central and peripheral respiratory drives in cats. II. Peripheral and central interaction of hypoxia and hypercapnia. Pflugers Arch. 1978;374:211–217. doi: 10.1007/BF00585597. [DOI] [PubMed] [Google Scholar]
- Guyenet PG, Koshiya N, Huangfu D, Verberne AJM, Riley TA. Central respiratory control of A5 and A6 pontine noradrenergic neurons. Am J Physiol Regul Integr Comp Physiol. 1993;264:R1035–R1044. doi: 10.1152/ajpregu.1993.264.6.R1035. [DOI] [PubMed] [Google Scholar]
- Guyenet PG, Stornetta RL, Bayliss DA, Mulkey DK. Retrotrapezoid nucleus. A litmus test for the identification of central chemoreceptors. Exp Physiol. 2005;90:247–253. doi: 10.1113/expphysiol.2004.029637. [DOI] [PubMed] [Google Scholar]
- Hayashi F, Coles SK, Bach KB, Mitchell GS, McCrimmon DR. Time-dependent phrenic nerve responses to carotid afferent activation: intact vs. decerebellate rats. Am J Physiol Regul Integr Comp Physiol. 1993;265:R811–R819. doi: 10.1152/ajpregu.1993.265.4.R811. [DOI] [PubMed] [Google Scholar]
- Hayashi F, Sinclair JD. Respiratory patterns in anesthetized rats before and after anemic decerebration. Respir Physiol. 1991;84:61–76. doi: 10.1016/0034-5687(91)90019-f. [DOI] [PubMed] [Google Scholar]
- Heeringa J, Berkenbosch A, DeGoede J, Olievier CN. Relative contribution of central and peripheral chemoreceptors to the ventilatory response to CO2 during hyperoxia. Respir Physiol. 1979;37:365–379. doi: 10.1016/0034-5687(79)90082-3. [DOI] [PubMed] [Google Scholar]
- Ilyinsky O, Tolstykh G, Mifflin S. Chronic hypoxia abolishes posthypoxia frequency decline in the anesthetized rat. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1322–R1330. doi: 10.1152/ajpregu.00033.2003. [DOI] [PubMed] [Google Scholar]
- Khoo MC, Gottschalk A, Pack AI. Sleep-induced periodic breathing and apnea: a theoretical study. J Appl Physiol. 1991;70:2014–2024. doi: 10.1152/jappl.1991.70.5.2014. [DOI] [PubMed] [Google Scholar]
- Lahiri S, DeLaney RG. Stimulus interaction in the responses of carotid body chemoreceptor single afferent fibers. Respir Physiol. 1975;24:249–266. doi: 10.1016/0034-5687(75)90017-1. [DOI] [PubMed] [Google Scholar]
- Lahiri S, Maret K, Sherpa MG. Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol. 1983;52:281–301. doi: 10.1016/0034-5687(83)90086-5. [DOI] [PubMed] [Google Scholar]
- Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, Prabhakar NR. Oxygen sensing in the body. Prog Biophys Mol Biol. 2006;91:249–286. doi: 10.1016/j.pbiomolbio.2005.07.001. [DOI] [PubMed] [Google Scholar]
- Millhorn DE, Eldridge FL, Waldrop TG. Prolonged stimulation of respiration by endogenous central serotonin. Respir Physiol. 1980;42:171–188. doi: 10.1016/0034-5687(80)90113-9. [DOI] [PubMed] [Google Scholar]
- Mitchell GS. Phrenic nerve responses to lung inflation and hypercapnia in decerebrate dogs. Pflugers Arch. 1990;416:580–585. doi: 10.1007/BF00382693. [DOI] [PubMed] [Google Scholar]
- Mitchell GS, Douse MA, Foley KT. Receptor interactions in modulating ventilatory activity. Am J Physiol Regul Integr Comp Physiol. 1990;259:R911–R920. doi: 10.1152/ajpregu.1990.259.5.R911. [DOI] [PubMed] [Google Scholar]
- Mulkey DK, Stornetta RL, Weston MC, Simmons JR, Parker A, Bayliss DA, Guyenet PG. Respiratory control by ventral surface chemoreceptor neurons in rats. Nat Neurosci. 2004;7:1360–1369. doi: 10.1038/nn1357. [DOI] [PubMed] [Google Scholar]
- Nattie E. Multiple sites for central chemoreception. Their roles in response sensitivity and in sleep and wakefulness. Respir Physiol. 2000;122:223–235. doi: 10.1016/s0034-5687(00)00161-4. [DOI] [PubMed] [Google Scholar]
- Nielsen AM, Bisguard GE, Mitchell GS. Phrenic nerve responses to hypoxia and CO2 in decerebrate dogs. Respir Physiol. 1986;65:267–283. doi: 10.1016/0034-5687(86)90012-5. [DOI] [PubMed] [Google Scholar]
- Olson EB, Bohne CJ, Dwinell MR, Podolsky A, Vidruk EH, Fuller DD, Powell FL, Mitchell GS. Ventilatory long-term facilitation in unanesthetized rats. J Appl Physiol. 2001;91:709–716. doi: 10.1152/jappl.2001.91.2.709. [DOI] [PubMed] [Google Scholar]
- Painter R, Khamnei S, Robbins R. A mathematical model of the human ventilatory response to isocapnic hypoxia. J Appl Physiol. 1993;74:2007–2015. doi: 10.1152/jappl.1993.74.4.2007. [DOI] [PubMed] [Google Scholar]
- Paton JF. A working heart–brainstem preparation of the mouse. J Neurosci Meth. 1996;65:63–68. doi: 10.1016/0165-0270(95)00147-6. [DOI] [PubMed] [Google Scholar]
- Pedersen ME, Fatemian M, Robbins PA. Identification of fast and slow ventilatory responses to carbon dioxide under hypoxic and hyperoxic conditions in humans. J Physiol. 1999;521:273–287. doi: 10.1111/j.1469-7793.1999.00273.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Powell FL, Milsom WK, Mitchell GS. Time domains of the hypoxic ventilatory response. Respir Physiol. 1998;112:123–134. doi: 10.1016/s0034-5687(98)00026-7. [DOI] [PubMed] [Google Scholar]
- Prabhakar NR. O2 sensing at the mammalian carotid body: why multiple O2 sensors and multiple transmitters? Exp Physiol. 2006;91:17–23. doi: 10.1113/expphysiol.2005.031922. [DOI] [PubMed] [Google Scholar]
- Richerson GB, Wang W, Hodges MR, Dohle CI, Diez-Sampedro A. Homing in on the specific phenotype(s) of central respiratory chemoreceptors. Exp Physiol. 2005;90:259–266. doi: 10.1113/expphysiol.2005.029843. [DOI] [PubMed] [Google Scholar]
- Robbins PA. Evidence for interaction between the contributions to ventilation from the central and peripheral chemoreceptors in man. J Physiol. 1988;401:503–518. doi: 10.1113/jphysiol.1988.sp017175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robbins PA. Hypoxic ventilatory decline: site of action. J Appl Physiol. 1995;79:373–374. doi: 10.1152/jappl.1995.79.2.373. [DOI] [PubMed] [Google Scholar]
- Schlenker EH, Prestbo A. Elimination of the post-hypoxic frequency decline in conscious rats lesioned in pontine A5 region. Respir Physiol Neurobiol. 2003;138:179–191. doi: 10.1016/s1569-9048(03)00187-3. [DOI] [PubMed] [Google Scholar]
- Skatrud JB, Dempsey JA. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol. 1983;55:813–822. doi: 10.1152/jappl.1983.55.3.813. [DOI] [PubMed] [Google Scholar]
- Smith CA, Jameson LC, Mitchell GS, Musch TI, Dempsey JA. Central–peripheral chemoreceptor interaction in awake cerebrospinal fluid-perfused goats. J Appl Physiol. 1984;56:1541–1549. doi: 10.1152/jappl.1984.56.6.1541. [DOI] [PubMed] [Google Scholar]
- Smith CA, Rodman JR, Chenuel BJ, Henderson KS, Dempsey JA. Response time and sensitivity of the ventilatory response to CO2 in unanesthetized intact dogs: central vs. peripheral chemoreceptors. J Appl Physiol. 2006;100:13–19. doi: 10.1152/japplphysiol.00926.2005. [DOI] [PubMed] [Google Scholar]
- Solin P, Roebuck T, Johns DP, Walters EH, Naughton MT. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med. 2000;162:2194–2200. doi: 10.1164/ajrccm.162.6.2002024. [DOI] [PubMed] [Google Scholar]
- St Croix CM, Cunningham DA, Paterson DH. Nature of the interaction between central and peripheral chemoreceptor drives in human subjects. Can J Physiol Pharmacol. 1996;74:640–646. doi: 10.1139/cjpp-74-6-640. [DOI] [PubMed] [Google Scholar]
- Takakura AC, Moreira TS, Colombari E, West GH, Stornetta RL, Guyenet PG. Peripheral chemoreceptor inputs to retrotrapezoid nucleus (RTN) CO2-sensitive neurons in rats. J Physiol. 2006;572:503–523. doi: 10.1113/jphysiol.2005.103788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teppema LJ, Dahan A. Central chemoreceptors. In: Ward DS, Dahan A, Teppema LJ, editors. Pharmacology and Pathophysiology of the Control of Breathing, Lung Biology in Health and Disease. New York: Marcel Dekker; 2005. pp. 21–70. [Google Scholar]
- Topor ZL, Vasilakos K, Remmers JE. Interaction of two chemoreflex loops in determining ventilatory stability. Nonlinear Studies. 2004;11:527–541. [Google Scholar]
- Turner DL, Mitchell GS. Long-term facilitation of ventilation following repeated hypoxic episodes in awake goats. J Physiol. 1997;499:543–550. doi: 10.1113/jphysiol.1997.sp021947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ursino M, Magosso E, Avanzolini G. An integrated model of the human ventilatory control system: the response to hypercapnia. Clin Physiol. 2001;21:447–464. doi: 10.1046/j.1365-2281.2001.00349.x. [DOI] [PubMed] [Google Scholar]
- Wilson RJ, Remmers JE, Paton JF. Brainstem PO2 and pH of the working heart–brain stem preparation during vascular perfusion with aqueous medium. Am J Physiol Regul Integr Comp Physiol. 2001;281:R528–R538. doi: 10.1152/ajpregu.2001.281.2.R528. [DOI] [PubMed] [Google Scholar]
- Xie A, Rutherford R, Rankin F, Wong B, Bradley TD. Hypocapnia and increased ventilatory responsiveness in patients with idiopathic central sleep apnea. Am J Respir Crit Care Med. 1995;152:1950–1955. doi: 10.1164/ajrccm.152.6.8520761. [DOI] [PubMed] [Google Scholar]






